Feb 7th 2023 - Mar 21st 2023
It’s not just the efficacy and safety of the produ... See more
The analyst comments "TGTX stock is up >15... See more
The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.
*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.Feb 7th 2023 - Mar 21st 2023
$GME GameStop shares surge as cost cuts drive surp... See more
The indicators on BBBY are overwhelmingly bullish,... See more
$COST almost!
$COST this dude 🤡🤣🤣🤣
$COST The bullish trend in the options market suggests a positive outlook for the stock We are seeing the $450 CALL having heavy activity which expire in 38 days.
$COST 💵long 💅
$COST 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣
$COST nice wedge here 🫡🔒 all I gottta say 🤫
$COST Love Costco as much as anyone
$COST 2hr looking bullish, she wanna touch the 200 day which is 296, juicy
$COST The chart points towards an optimistic outlook for the stock.
$COST Always a buy in the 470s, congratulations to those who got it this a.m.
It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Each treatment cost under $10k per treatment.
Each treatment cost under $10k per treatment.
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
$GME GameStop shares surge as cost cuts drive surprise profit https://newsfilter.io/a/3d33b0998d4bbfc887d6f24eea654ef2
The indicators on BBBY are overwhelmingly bullish, the short interest is over 100%, the cost to borrow has been over 100% and climbing for a while, and lastly (most importantly) the fails to deliver are out of control.
$SNDL WE BUY, WE EXPAND, WE TRIPLE REVENUE, WE REDUCE COSTS, WE LOAN CAPITAL, WE GROW WORLDWIDE, WE ARE DEBT FREE.
Increasing cost to borrow, share prices rising, and the PR’s are undeniably positive.
$GME iTs coSt noThin to hoLd!
56% cost to borrow 4m market cap 15m float $7 52 week high‼️ ESP UP 110% More revenue then market cap Beautiful chart I am long this for the next JCSE ATXG GSUN $AMC $GME
Cost savings are astronomical - you don’t have to chop limbs off of DM pts.
HE HAS NEVER BEEN WRONG!!!! YOU KNOW ITS LEGIT BECAUSE HIS SERVICE COSTS $2000 A YEAR (NO REFUNDS UNLESS YOU HAVE A LAWYER)
Still very short and also thank you for dramatically reducing the borrow cost of your paper handed Ape shares.
